دورية أكاديمية

Effectiveness of inactivated COVID-19 vaccine CoronaVac in children aged less than 3 years old during Omicron wave in Hong Kong.

التفاصيل البيبلوغرافية
العنوان: Effectiveness of inactivated COVID-19 vaccine CoronaVac in children aged less than 3 years old during Omicron wave in Hong Kong.
المؤلفون: Wong WHS; Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong SAR, China., Leung DL; Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong SAR, China., Yip KM; Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong SAR, China., So HK; Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong SAR, China., Rosa Duque JS; Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong SAR, China. Electronic address: jsrduque@hku.hk., Lau YL; Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong SAR, China. Electronic address: lauylung@hku.hk.
المصدر: Vaccine [Vaccine] 2024 Apr 02; Vol. 42 (9), pp. 2135-2137. Date of Electronic Publication: 2024 Mar 07.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
أسماء مطبوعة: Publication: Amsterdam, The Netherlands : Elsevier Science
Original Publication: [Guildford, Surrey, UK] : Butterworths, [c1983-
مواضيع طبية MeSH: COVID-19 Vaccines* , COVID-19*/prevention & control , Vaccines, Inactivated*, Child ; Humans ; Child, Preschool ; Hong Kong/epidemiology ; Pandemics
مستخلص: The COVID-19 pandemic has affected people of all ages worldwide. However, there is still no information on the vaccine effectiveness (VE) of inactivated COVID-19 vaccines in children aged less than 3 years old. This study highlighted that 2 doses of CoronaVac were effective in preventing COVID-19, with a VE of 83.1 %.
Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Hong Kong Special Administrative Region Government. All other authors declare no competing interests].
(Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
فهرسة مساهمة: Keywords: COVID-19; CoronaVac; Omicron; Vaccine; Young children
المشرفين على المادة: 0 (sinovac COVID-19 vaccine)
0 (COVID-19 Vaccines)
0 (Vaccines, Inactivated)
تواريخ الأحداث: Date Created: 20240307 Date Completed: 20240408 Latest Revision: 20240408
رمز التحديث: 20240408
DOI: 10.1016/j.vaccine.2024.02.067
PMID: 38453618
قاعدة البيانات: MEDLINE
الوصف
تدمد:1873-2518
DOI:10.1016/j.vaccine.2024.02.067